MGH Office-Based Opioid Treatment in Chelsea, MA
The Massachusetts General Hospital (MGH) Office-Based Opioid Treatment (OBOT) program, located at the MGH Chelsea HealthCare Center at 151 Everett Avenue, offers comprehensive and compassionate care for individuals struggling with opioid use disorder (OUD). This service provides a confidential and supportive environment for patients seeking recovery, integrating addiction treatment into a primary care setting. By making treatment accessible within the community, MGH aims to remove barriers and reduce the stigma often associated with addiction treatment.
Integrated and Personalized Care
The MGH OBOT model emphasizes personalized treatment plans tailored to the unique needs of each patient. This approach recognizes that recovery is a complex journey, and success often relies on addressing not just the substance use itself, but also co-occurring physical and mental health issues. Treatment is delivered by a dedicated team of professionals, including doctors, nurses, social workers, and behavioral health specialists, ensuring a holistic perspective on well-being.
Core Treatment Services
A cornerstone of the program is Medication-Assisted Treatment (MAT), primarily utilizing medications such as buprenorphine/naloxone (Suboxone) to manage cravings and withdrawal symptoms. MAT is considered the gold standard for treating OUD and significantly improves retention in treatment and reduces the risk of overdose. However, pharmacotherapy is just one component; the program integrates behavioral health support for comprehensive recovery.
Key Program Components Include:
- Medication Management (MAT)
- Individual and Group Counseling
- Screening and Treatment for Co-occurring Mental Health Conditions
- Case Management and Referrals to Community Resources
- Ongoing Monitoring and Relapse Prevention Planning
Location and Accessibility
Situated within the Mass General Chelsea HealthCare Center at 151 Everett Avenue, this OBOT program is conveniently located for residents of Chelsea and surrounding communities. Integrating addiction treatment within a primary care setting makes it easier for patients to access general medical care simultaneously, promoting overall health and long-term recovery. The commitment of MGH to community health ensures high-quality care is delivered close to home.
Frequently Asked Questions (FAQs)
Is this program only for residents of Chelsea?
No, while the program is physically located in Chelsea, it is open to any individual seeking treatment for opioid use disorder, regardless of their place of residence.
What type of medication is used in the treatment?
The program primarily utilizes Medication-Assisted Treatment (MAT), often including buprenorphine/naloxone (Suboxone), which helps reduce cravings and withdrawal symptoms associated with opioid dependence.
Do I need a referral to start treatment?
While often helpful, a referral is not always required. You can contact the MGH Chelsea HealthCare Center directly to inquire about scheduling an assessment and beginning the intake process for the OBOT program.
